U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07687043) titled 'Buyang Huanwu Decoction With Wuling Powder for Acute Ischemic Stroke' on June 28.
Brief Summary: Acute ischemic stroke is a common cause of disability. Standard Western medical treatment is widely used, but some patients continue to have neurological impairment and difficulty with daily activities after stroke.
This study evaluated whether Buyang Huanwu Decoction combined with Wuling Powder, when added to standard Western medical treatment, could help improve recovery in patients with acute ischemic stroke. Eligible patients were randomly assigned to receive either standard Western medical treatment alone or standard Western medical...